LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 32.28 | 770.25 | 1502 | 3392 | 0.4427 | 0.3664 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 32.28 | 770.25 | 1285 | 3392 | 0.3787 | 0.2703 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 34.50 | 770.25 | 1554 | 3712 | 0.4186 | 0.3626 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 34.50 | 770.25 | 1351 | 3712 | 0.3640 | 0.2810 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 36.73 | 770.25 | 1582 | 4086 | 0.3872 | 0.3485 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 36.73 | 770.25 | 1423 | 4086 | 0.3483 | 0.2904 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 38.95 | 770.25 | 1665 | 4543 | 0.3664 | 0.3513 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 38.95 | 770.25 | 1452 | 4543 | 0.3196 | 0.2810 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 41.17 | 770.25 | 1742 | 5010 | 0.3477 | 0.3527 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 41.17 | 770.25 | 1525 | 5010 | 0.3044 | 0.2877 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 43.39 | 770.25 | 1851 | 5404 | 0.3425 | 0.3661 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 43.39 | 770.25 | 1522 | 5404 | 0.2816 | 0.2742 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 45.61 | 770.25 | 1965 | 5813 | 0.3380 | 0.3788 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 45.61 | 770.25 | 1659 | 5813 | 0.2854 | 0.3010 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 47.83 | 770.25 | 2063 | 6223 | 0.3315 | 0.3866 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 47.83 | 770.25 | 1685 | 6223 | 0.2708 | 0.2965 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 50.05 | 770.25 | 2134 | 6629 | 0.3219 | 0.3884 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 50.05 | 770.25 | 1850 | 6629 | 0.2791 | 0.3260 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 52.27 | 770.25 | 2254 | 7058 | 0.3193 | 0.3993 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 52.27 | 770.25 | 1975 | 7058 | 0.2798 | 0.3426 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 54.49 | 770.25 | 2331 | 7555 | 0.3085 | 0.3996 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 54.49 | 770.25 | 2038 | 7555 | 0.2697 | 0.3436 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 56.71 | 770.25 | 2527 | 8001 | 0.3158 | 0.4217 | MN20160304_L02 | G10 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 56.71 | 770.25 | 2205 | 8001 | 0.2756 | 0.3654 | MN20160304_L02 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.01 | 58.94 | 770.25 | 2543 | 8444 | 0.3012 | 0.4130 | MN20160304_L02 | G10 |